Stock analysis, trade plans, and proprietary indicators by Trend Edge.
Trend Edge Setup Score
Trend Edge rates TBPH Bullish with a Setup Score of 35, net conviction 28, actionability 44. How the Setup Score works →
Total Setup Score
35
Directional Bias
Bullish
Net Conviction
28
Actionability
44 (in range)
Key signals behind this score
40wk Uptrend — trend only (sma 17.08 vs px 16.98)
Fresh Trend Turn — 200wk turn 42w+10wk turn 7w
80wk Uptrend — rising+above (sma 13.87 vs px 16.98)
200wk Uptrend — rising+above (sma 11.41 vs px 16.98)
Funds Accumulating — momZ +0.15 · 1.91→1.90
Short Squeeze Setup — velZ +0.19 · age 96w×0.45 · 20.19%
Seasonal Tailwind — august med 4.7% (mag 2/3) · posClose 66.67% (rel 2/3) · n12 ×0.75 = 6
About Theravance Biopharma Inc
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational, once-daily norepinephrine reuptake inhibitor, Which is in Phase 3 clinical trials for symptomatic neurogenic orthostatic hypotension (nOH) in patients… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: May 16, 2014
Headquarters: 901 Gateway Boulevard, South San Francisco, CA, United States, 94080
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$16.67
Near-term / short-term trend
Weekly
40-Week SMA
$17.08
Medium-term trend
Weekly
80-Week SMA
$13.87
Cyclical trend (business cycle)
Weekly
200-Week SMA
$11.41
Secular trend (multi-year)
Monthly
10-Month SMA
$17.38
Near-term monthly trend
Monthly
20-Month SMA
$14.02
Medium-term monthly trend
Monthly
40-Month SMA
$11.74
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Theravance Biopharma Inc
(TBPH) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.